Berlin Cures Holding AG

Berlin Cures Holding AG
Specialist MarketBiotech
Contact+44 (0)20 3854 7700
Emailgeorge.hebden-lee@mantellassociates.com

“George is an extremely dedicated headhunter. He is very well structured and always takes you along very well by telling you what the next steps are. He adheres to timelines 100%. After each interview he gets feedback from the candidate but also from the recruiter. He is always extremely friendly. I recommend him 100%.”

Medical Director, Berlin Cures Holding AG

“It was a real pleasure to work with Mantell Associates, their professionalism as a recruitment specialist was a joy. I would most heartily recommend MA to those seeking the thoughtful guidance of a highly experienced and engaging person.”

CEO, Berlin Cures Holding AG

 

Berlin Cures was first to follow up on the scientific finding that there are a large number of diseases associated with pathological functional autoantibodies directed against G protein-couples receptors. Heart failure and Long Covid belong to this group of diseases. Their aptamer BC 007 can neutralize these autoantibodies and this is the reason why Berlin Cures has been working for decades to develop a product based on scientific findings that may help many suffering patients.

 

Company website – https://www.berlincures.de/en/

​To find out more about Berlin Cures Holding AG, contact George Hebden Lee on +44 (0)20 3854 7700 or george.hebden-lee@mantellassociates.com.